1. Academic Validation
  2. Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan

Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan

  • Nat Genet. 2012 May;44(5):581-5. doi: 10.1038/ng.2253.
Tony Roscioli 1 Erik-Jan Kamsteeg Karen Buysse Isabelle Maystadt Jeroen van Reeuwijk Christa van den Elzen Ellen van Beusekom Moniek Riemersma Rolph Pfundt Lisenka E L M Vissers Margit Schraders Umut Altunoglu Michael F Buckley Han G Brunner Bernard Grisart Huiqing Zhou Joris A Veltman Christian Gilissen Grazia M S Mancini Paul Delrée Michèl A Willemsen Danijela Petković Ramadža David Chitayat Christopher Bennett Eamonn Sheridan Els A J Peeters Gita M B Tan-Sindhunata Christine E de Die-Smulders Koenraad Devriendt Hülya Kayserili Osama Abd El-Fattah El-Hashash Derek L Stemple Dirk J Lefeber Yung-Yao Lin Hans van Bokhoven
Affiliations

Affiliation

  • 1 Department of Human Genetics, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Abstract

Walker-Warburg syndrome (WWS) is an autosomal recessive multisystem disorder characterized by complex eye and brain abnormalities with congenital muscular dystrophy (CMD) and aberrant a-dystroglycan glycosylation. Here we report mutations in the ISPD gene (encoding isoprenoid synthase domain containing) as the second most common cause of WWS. Bacterial IspD is a nucleotidyl transferase belonging to a large glycosyltransferase family, but the role of the orthologous protein in chordates is obscure to date, as this phylum does not have the corresponding non-mevalonate isoprenoid biosynthesis pathway. Knockdown of ispd in zebrafish recapitulates the human WWS phenotype with hydrocephalus, reduced eye size, muscle degeneration and hypoglycosylated a-dystroglycan. These results implicate ISPD in a-dystroglycan glycosylation in maintaining sarcolemma integrity in vertebrates.

Figures